Open Journal of Obstetrics and Gynecology
Vol.08 No.11(2018), Article ID:87536,8 pages

Standardization of Sampling for Isolation of Exosome-Like Small-Extracellular Vesicles from Peripheral Blood from Reproductive-Aged Women

Jéssica Maria Diehl1, Júlia Abbade Tronco1, Natália Prearo Moço2, Graziela Gorete Romagnoli3, Ana Clara Faquineli Cavalcante Mendes de Avila4, Juliano Coelho da Silveira4, Márcia Guimarães da Silva1, Bruna Ribeiro de Andrade Ramos1*

1Department of Pathology, Botucatu Medical School, São Paulo State University (UNESP), Botucatu, Brasil

2Três LagoasIntegrated College―FITL/AEMS, Três Lagoas, Brasil

3Department of Microbiology and Immunology, Biosciences Institute, São Paulo State University (UNESP), Botucatu, Brasil

4Department of Veterinary Medicine, Faculty of Zoology and Food Engineering, São Paulo University, Pirassununga, Brasil

Copyright © 2018 by authors and Scientific Research Publishing Inc.

This work is licensed under the Creative Commons Attribution International License (CC BY 4.0).

Received: August 18, 2018; Accepted: September 24, 2018; Published: September 27, 2018


Exosome-like small-extracellular vesicles (sEVs) are extracellular vesicles that act in intercellular communication and are involved in several biologic and pathologic processes. While sEVs increase the stability of their cargo molecules, there is still a need for standardization of sampling and isolation of these microvesicles. We aimed to determine the best sampling method for isolation of sEVs from peripheral blood from reproductive-aged women. Material and Methods: We included samples of plasma from our biobank collected in 2014 by venipuncture in heparin tubes and stored at −80˚C. We also included blood samples collected in heparin tubes and Ethylenediamine tetraacetic acid (EDTA) tubes and stored at −80˚C for one to two weeks prior processing. All blood samples were collected from the same nine reproductive-aged female volunteers. sEVs were isolated from plasma by ultracentrifugation and filtration and indirectly quantified using Pierce BCA Protein Assay kit. Transmission electron microscopy (TEM) and Nano Tracking Analysis (NTA) were performed to confirm the isolation of sEVs. Results and Discussion: TEM and NTA confirmed the isolation of sEVs. Protein concentration of short-time stored heparin samples was not statistically different from long-time stored heparin samples (1847.2 ± 651.4 vs. 2363.2 ± 1025.1, p = 0.14). There was no difference between heparin and EDTA plasma samples recently collected (2363.2 ± 1025.1 vs. 2044.8 ± 653.2, p = 0.44). In conclusion, blood samples may be collected using heparin or EDTA for isolation of sEVs. Long-time stored plasma samples maintain sEVs integrity and may be used, especially in comparative studies.


Exosome-Like Small-Extracellular Vesicles, Plasma, Reproductive-Aged Women

1. Introduction

Exosome-like small-extracellular vesicles (sEVs) are doubled-membrane vesicles with a diameter that varies between 30 to 150 nm that along with microvesicles and apoptotic bodies form the heterogeneous group of extracellular vesicles [1] [2] . These vesicles are classified according to their size, components and generation mechanisms and can be found in different biological fluids such as blood and cerebrospinal fluid [3] .

sEVs are important regulators of immune response and act as crucial mediators of cellular communication in several physiologic and pathologic processes by serving as vehicles for transfer of different molecules between cells [4] [5] . They have been described to carry a variety of molecules such as membrane and cytosolic proteins, lipids and nucleic acids [6] . sEVs represent a rich source of prospective biomarkers studies in many fields as they confer stability to their cargo and can orientate their content to specific types of cells [3] .

The best-characterized mechanism for exosome formation involves the recruitment of the endosomal sorting complex required for transport machinery to ubiquitinated proteins in the early endosome. An alternative pathway has been recently described and involves synthesis of ceramide as a mechanism to induce vesicle curvature and budding. A third biogenesis mechanism that has been proposed is tetraspanin-mediated organization of specific proteins such as the amyloidogenic protein pre-melanosome protein [7] .

Several studies have analyzed the potential role of sEVs and their molecular content as biomarkers in different diseases including gestational pathologies such as pre-eclampsia (PE) and gestational diabetes. This type of investigation can be especially useful once it can be performed using fairly non-invasive samples such as blood. In a recent study Pillay et al. [8] have reported that total placental-derived exosomes was increased in pre-eclamptic patients when compared with normotensive women. Salomon et al. [9] have demonstrated that two types of microRNA (has-miR-486-1-5p and has-miR-486-2-5p) were upregulated in exosomes from peripheral blood of pregnant women with PE when compared to non complicated pregnancies. Another study from the same group identified that the exosome concentration was significantly higher in the gestational diabetes group than in normal pregnancies matched by gestational age [10] .

Besides their role as prominent biomarkers, these nanovesicles also hold a promise for therapeutic use. They have the potential to be used as a drug delivery vehicle since they have the desirable features of an ideal drug delivery system such as long circulating half-life, the intrinsic ability to target tissues, biocompatibility and minimal toxicity issues. sEVs also offer a major advantage because there is no unwanted accumulation or homing in the liver and they avoid the first pass metabolic effect [11] [12] . These microvesicles have also shown the ability to induce tissue regeneration by delivering growth factors, proteins, miRNA, non-coding RNA, mRNA and lipids. In a myocardial infarction, for example, sEVs derived from stem cells have been able to regenerate cardiac tissue [13] .

In this scenario, optimization of sampling and isolation of sEVs are important to obtain improved and reliable results. We aimed to determine the best sampling method for isolation of sEVs from peripheral blood of reproductive-aged women considering the storage length and the type of anticoagulant.

2. Material and Methods

2.1. Sampling

We included samples of plasma from our biobank collected in 2014 by venipuncture in heparin tubes and stored at −80˚C. We also included blood samples collected in heparin tubes and EDTA tubes and stored at −80˚C for one to two weeks prior processing. Inclusion criteria were reproductive aged women fasting for at least one hour prior blood collection. Sleep deprived women or those with coagulation disorders were excluded as these conditions may affect levels of sEVs. All blood samples were collected from the same nine reproductive aged female volunteers (convenience sample method) by venous puncture in sterile tubes and plasma was obtained by centrifugation at 1800 g for 10 minutes.

2.2. Isolation of Small-Extracellular Vesicles

sEVs were isolated using aliquots of 2 mL of plasma following the ultracentrifugation protocol adapted from Lässer et al. [14] . First, samples were centrifuged at 20,000 g for 30 minutes to remove cell debris. Then, the supernatant was transferred to a falcon tube and diluted with 4 mL of cold sterile PBS (phosphate buffered saline). This mix was filtered using a sterile syringe filter pore size 0.20 µm (Millipore) and ultracentrifuged at 120,000 g for 90 minutes. At this stage, the supernatant was discarded and the pellet containing the sEVs were resuspended in 200 µL of cold sterile PBS and stored in sterile tubes at −80˚C. All the centrifugation stages were performed at 4˚C.

2.3. Indirect Quantification of sEVs

Considering that sEVs are coated by proteins, we performed the protein quantification of the isolated sEVs using the Pierce BCA Protein Kit (Thermo Scientific) according to the instructions provided by the manufacturer.

2.4. Characterization of sEVs

Transmission electron microscopy (TEM) was performed to visually confirm the isolation of sEVs. Briefly, sEVs-PBS suspension were added to a nickel grid with formvar for 1 hour then washed three times with PBS and treated after every wash using paraformaldehyde 2%, glutaraldehyde 2.5% and uranyl acetate 2%. Then samples were finally fixed (metil celulose 0.13% and uranyl acetate 0.4%) and visualized by TEM (Tecnai Spirit).

Additionally, sEVs size was measured using a Nanosight NS300 Instrument (Malvern) and analyzed with NanoSight Nano Tracking Analysis (NTA) Software v3.1. Videos (5 × 30 s) were acquired after the manual introduction of EV samples (diluted 1:500 in PBS), at camera level 13, temperature (37˚C), and by reference to 50, 100, and 150-nm calibration beads (Malvern) to verify accuracy. Vesicle size and concentration were defined as mode and mean according to the acquired videos using a detection threshold of 3.

2.5. Statistical Analysis

Paired T test was used to compare protein quantification between long vs. short time stored and heparin vs. EDTA using the software GraphPad Prism 5.0. A p value of 0.05 was considered statistically significant.

3. Results

Median age of the participants was 28.6 years old (±3.1). All the participants were non-smokers and non-drug users. Their sociodemographic characteristics are shown in Table 1.

Successful isolation of sEVs was visually confirmed by TEM (Figure 1). NTA also confirmed the isolation of sEVs. The medium size of the particles was 96.6 ± 20.0 nm and medium concentration was 1.0 × 1011 ± 5.3 × 1010 particles/mL, a size compatible with the diameter described for sEVs (Figure 2).

Regarding indirect quantification of sEVs, protein quantification of short time stored heparin samples was not statistically different from long time stored heparin samples (2363.2 ± 1025.1 µg vs. 1847.2 ± 651.4 µg, p = 0.14). Similarly, there was no difference in protein concentration between recently collected heparin and EDTA plasma samples (2363.2 ± 1025.1 µg vs. 2044.8 ± 653.2 µg, p = 0.44).

4. Discussion

Communication is critical for survival in the natural environment. On an intercellular level communication can be mediated by extracellular vesicles. All organisms, from bacteria [15] to animals [16] are known to produce these vesicles and they have been identified in several human body fluids, such as blood [17] , breast milk [18] [19] , ejaculate [20] and also in tissues including tumors [21] . Thus, understanding extracellular vesicles-mediated communication is important for both basic science and translational research.

Table 1. Sociodemographis characteristics of participants.

Variables age presented as mean (±SD). Remaining variables presented as percentage.

Figure 1. Electron micrograph of sEVs (arrows). The scale bar represents 200 nm (×23,000).

Figure 2. Concentration and size of particles by NTA. The y-axis represents concentration of particles per ml and the x-axis shows their size.

Purification methods and sample preparation techniques may indirectly select for some subpopulations of vesicles with specific biochemical or physical characteristics over others, possibly affecting the ultimate outcome of experiments [22] . Therefore, standardization of sEVs isolation is an essential step to studies that aim to characterize their cargo in biological and pathological processes and also for therapeutic purposes.

In the present study we did not observe statistical differences in sEVs concentration indirectly measured by protein quantification between two types of anticoagulants commonly used to collect blood samples, heparin and EDTA. This indicates that blood samples may be collected using either anticoagulant for isolation of sEVs.

Nevertheless, further investigation must be performed to evaluate downstream applications. A recent report by the International Society of Extracellular Vesicles recommends to avoid the use of heparin as anticoagulant when molecular techniques such as real time PCR is to be performed. According to this report, heparin competes with primers and/or enzymes for binding to acid nucleic and a prior heparinase treatment is recommended [23] .

Regarding length of storage, we did not observe statistical differences between long-time stored plasma and recently collected samples. While collection of fresh material may result in more fidelity in absolute quantification of sEVs, our results demonstrate that long time stored plasma maintains sEVs integrity and may be used, especially in comparative studies.


We acknowledge the volunteers that had donated blood samples for this experiment. This work was supported by São Paulo Research Foundation (Fapesp) (grants 2016/13616-8, 2016/16618-1, 2016/01340-8 and 2015/21829-9). The sponsor had no role in study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.

Conflicts of Interest

The authors declare no conflicts of interest regarding the publication of this paper.

Cite this paper

Diehl, J.M., Tronco, J.A., Moço, N.P., Romagnoli, G.G., de Avila, A.C.F.C.M., da Silveira, J.C., da Silva, M.G. and de Andrade Ramos, B.R. (2018) Standardization of Sampling for Isolation of Exosome-Like Small-Extracellular Vesicles from Peripheral Blood from Reproductive-Aged Women. Open Journal of Obstetrics and Gynecology, 8, 1063-1070.


  1. 1. Mathivanan, S., Ji, H. and Simpson, R.J. (2010) Exosomes, Extracellular Organelles Important in Intercellular Communication. Journal of Proteomics, 73, 1907-1920.

  2. 2. McGough, I.J. and Vincent, J.P. (2016) Exosomes in Developmental Signalling. Development, 143, 2482-2493.

  3. 3. Abels, E.R. and Breakefield, X.O. (2016) Introduction to Extracellular Vesicles. Biogenesis, RNA Cargo Selection, Content, Release, and Uptake. Cellular and Molecular Neurobiology, 36, 301-312.

  4. 4. Valadi, H., Ekstrom, K., Bossios, A., Sjostrand, M., Lee, J.J. and Lotvall, J.O. (2007) Exosome-Mediated Transfer of mRNAs and microRNAs Is a Novel Mechanism of Genetic Exchange between Cells. Nature Cell Biology, 9, 654-659.

  5. 5. Greening, D.W., Gopal, S.K., Xu, R., Simpson, R.J. and Chen, W. (2015) Exosomes and Their Roles in Immune Regulation and Cancer. Seminars in Cell & Developmental Biology, 40, 72-81.

  6. 6. Maas, S.L.N., Breakefield, X.O. and Weaver, A.M. (2017) Extracellular Vesicles, Unique Intercellular Delivery Vehicles. Trends in Cell Biology, 27, 3.

  7. 7. Théry, C., Zitvoge, L. and Amigorena, S. (2002) Exosomes, Composition, Biogenesis and Function. Nature Reviews Immunology, 2, 571.

  8. 8. Pillay, P., Maharaj, N., Moodley, J. and Mackraj, I. (2016) Placental Exosomes and Pre-Eclampsia, Maternal Circulating Levels in Normal Pregnancies and, Early and Late Onset Pre-Eclamptic Pregnancies. Placenta, 46, 18-25.

  9. 9. Salomon, C., Guanzon, D., Scholz-Romero, K., Longo, S., Correa, P., Illanes, S.E., et al. (2017) Placental Exosomes as Early Biomarker of Preeclampsia, Potential Role of Exosomal MicroRNAs across Gestation. The Journal of Clinical Endocrinology & Metabolism, 102, 3182-3194.

  10. 10. Salomon, C., Scholz-Romero, K., Sarker, S., Sweeney, E., Kobayashi, M., Correa, P., et al. (2016) Gestational Diabetes Mellitus Is Associated with Changes in the Concentration and Bioactivity of Placenta-Derived Exosomes in Maternal Circulation across Gestation. Diabetes, 65, 598-609.

  11. 11. Lai, R.C., Yeo, R.W., Tan, K.H. and Lim, S.K. (2013) Exosomes for Drug Delivery—A Novel Application for the Mesenchymal Stem Cell. Biotechnology Advances, 31, 543-51.

  12. 12. Wiklander, O.P., Nordin, J.Z., O'Loughlin, A., Gustafsson, Y., Corso, G., Mager, I., et al. (2015) Extracellular Vesicle in Vivo Biodistribution Is Determined by Cell Source, Route of Administration and Targeting. Journal of Extracellular Vesicles, 4, 26316.

  13. 13. Ha, D., Yang, N. and Nadithe, V. (2016) Exosomes as Therapeutic Drug Carriers and Delivery Vehicles across Biological Membranes, Current Perspective and Future Challenges. Acta Pharmaceutica Sinica, 6, 287-296.

  14. 14. Lasser, C., Elgh, M. and Lotvall, J. (2012) Isolation and Characterization of RNA-Containing Exosomes. Journal of Visualized Experiments, 9, e3037.

  15. 15. Brown, L., Wolf, J.M., Prados-Rosales, R. and Casadevall, A. (2015) Through the Wall, Extracellular Vesicles in Gram-Positive Bacteria, Mycobacteria and Fungi. Nature Reviews Microbiology, 13, 620-611.

  16. 16. Colombo, M., Raposo, G. and Thery, C. (2014) Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles. Annual Review of Cell and Developmental Biology, 30, 255-289.

  17. 17. Yuana, Y., Koning, R.I., Kuil, M.E., Rensen, P.C., Koster, A.J., Bertina, R.M., et al. (2013) Cryo-Electron Microscopy of Extracellular Vesicles in Fresh Plasma. Journal of Extracellular Vesicles, 2, 21494.

  18. 18. Zonneveld, M.I., Brisson, A.R., Van Herwijnen, M.J., Tan, S., van de Lest, C.H., Redegeld, F.A., et al. (2014) Recovery of Extracellular Vesicles from Human Breast Milk Is Influenced by Sample Collection and Vesicle Isolation Procedures. Journal of Extracellular Vesicles, 3, 24215.

  19. 19. Lasser, C., Alikhani, V.S., Ekstrom, K., Eldh, M., Paredes, P.T., Bossios, A., et al. (2011) Human Saliva, Plasma and Breast Milk Exosomes Contain RNA, Uptake by Macrophages. Journal of Translational Medicine, 9, 9.

  20. 20. Hoog, J.L. and Lotvall, J. (2015) Diversity of Extracellular Vesicles in Human Ejaculates Revealed by Cryo-Electron Microscopy. Journal of Extracellular Vesicles, 4, 28680.

  21. 21. Tkach, M. and Théry, C. (2016) Communication by Extracellular Vesicles, Where We Are and Where We Need to Go. Cell, 164, 1226-1232.

  22. 22. Baranyai, T., Herczeg, K., Onodi, Z., Voszka, I., Módos, K., Marton, N., et al. (2015) Isolation of Exosomes from Blood Plasma, Qualitative and Quantitative Comparison of Ultracentrifugation and Size Exclusion Chromatography Methods. PLoS One, 10, e0145686.

  23. 23. Witwer, K.W., Buzás, E.I., Bemis, L.T., Bora, A., Lasser, C., Lotvall, J., et al. (2013) Standardization of Sample Collection, Isolation and Analysis Methods in Extracellular Vesicle Research. Journal of Extracellular Vesicles, 2, 20360.